0000899243-15-002562.txt : 20150806 0000899243-15-002562.hdr.sgml : 20150806 20150806163207 ACCESSION NUMBER: 0000899243-15-002562 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150804 FILED AS OF DATE: 20150806 DATE AS OF CHANGE: 20150806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001338042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202960116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 500-7867 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc DATE OF NAME CHANGE: 20050906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weger Mary CENTRAL INDEX KEY: 0001638460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 151033600 MAIL ADDRESS: STREET 1: ONE MAIN STREET, SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-04 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001638460 Weger Mary C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 0 1 0 0 Chief Performance Officer Stock Option (right to buy) 19.52 2015-08-04 4 A 0 40000 0.00 A 2025-08-04 Common Stock 40000 40000 D The stock option award was made to the Reporting Person as part of a retention arrangement approved by the Issuer's Board of Directors on August 4, 2015. The stock option award has an exercise price equal to the fair market value of the closing price of the Issuer on the date of the grant. 25% of the shares of common stock underlying this stock option award will vest on August 4, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through August 4, 2019, subject to the Reporting Person's continued employment with the Issuer. /s/ Jennifer Fitzpatrick, as attorney-in-fact 2015-08-06